Efficacy and safety of apatinib in advanced refractory soft tissue sarcoma and association with histologic subtypes: a multicenter retrospective study

BACKGROUND: Antiangiogenic therapy is a potential strategy against advanced refractory soft tissue sarcoma (STS). This retrospective study aimed to assess the efficacy and safety of apatinib in patients with advanced refractory STS and explore its clinical effect on the different histologic subtypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiangling, Wang, Jian, Sun, Baoyong, Sun, Yuping, Liu, Ning, Niu, Xuecai, Li, Chunhua, Li, Li, Zhang, Qiang, Hao, Jing, Wang, Xiuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577742/
https://www.ncbi.nlm.nih.gov/pubmed/36267758
http://dx.doi.org/10.21037/atm-22-3250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577742/
https://www.ncbi.nlm.nih.gov/pubmed/36267758
http://dx.doi.org/10.21037/atm-22-3250

Ejemplares similares